Drug resistance in Indian visceral leishmaniasis
Top Cited Papers
Open Access
- 1 November 2001
- journal article
- review article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 6 (11) , 849-854
- https://doi.org/10.1046/j.1365-3156.2001.00778.x
Abstract
Throughout the world, pentavalent antimonial compounds (Sbv) have been the mainstay of antileishmanial therapy for more than 50 years. Sbv has been highly effective in the treatment of Indian viscera...Keywords
This publication has 18 references indexed in Scilit:
- Short‐Course of Oral Miltefosine for Treatment of Visceral LeishmaniasisClinical Infectious Diseases, 2000
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovaniThe Journal of Infectious Diseases, 1999
- Response to Interferon‐γ plus Pentavalent Antimony in Indian Visceral LeishmaniasisThe Journal of Infectious Diseases, 1997
- Cure of Antimony-Unresponsive Indian Visceral Leishmaniasis with Amphotericin B Lipid ComplexThe Journal of Infectious Diseases, 1996
- Immunochemotherapy for a Systemic Intracellular Infection: Accelerated Response Using Interferon- in Visceral LeishmaniasisThe Journal of Infectious Diseases, 1995
- Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azarThe Lancet, 1994
- Comparison of regimens of treatment with sodium stibogluconate in kala-azar.BMJ, 1984
- Evaluation of diamidine compound (pentamidine isethionate) in the treatment of resistant cases of kala-azar occurring in North Bihar, IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983